November 4, 2021 Journal article Open Access

Ayoubi, Riham; Alshafie, Walaa; McPherson, Peter S.; Laflamme, Carl

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="DOI">10.5281/zenodo.5644346</identifier>
  <creators>
    <creator>
      <creatorName>Ayoubi, Riham</creatorName>
      <givenName>Riham</givenName>
      <familyName>Ayoubi</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-6633-655X</nameIdentifier>
      <affiliation>Montreal Neurological Institute</affiliation>
    </creator>
    <creator>
      <creatorName>Alshafie, Walaa</creatorName>
      <givenName>Walaa</givenName>
      <familyName>Alshafie</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-7999-1297</nameIdentifier>
      <affiliation>Montreal Neurological Institute</affiliation>
    </creator>
    <creator>
      <creatorName>McPherson, Peter S.</creatorName>
      <givenName>Peter S.</givenName>
      <familyName>McPherson</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-7806-5662</nameIdentifier>
      <affiliation>Montreal Neurological Institute</affiliation>
    </creator>
    <creator>
      <creatorName>Laflamme, Carl</creatorName>
      <givenName>Carl</givenName>
      <familyName>Laflamme</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-5906-025X</nameIdentifier>
      <affiliation>Montreal Neurological Institute</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Antibody Characterization Report for Matrin-3</title>
  </titles>
  <publisher>Zenodo</publisher>
  <publicationYear>2021</publicationYear>
  <subjects>
    <subject>Matrin-3</subject>
    <subject>matrin-3</subject>
    <subject>MATR3</subject>
    <subject>matr3</subject>
    <subject>P43243</subject>
    <subject>antibody characterization</subject>
    <subject>antibody validation</subject>
    <subject>Amyotrophic lateral sclerosis</subject>
    <subject>ALS-RAP</subject>
  </subjects>
  <dates>
    <date dateType="Issued">2021-11-04</date>
  </dates>
  <resourceType resourceTypeGeneral="JournalArticle"/>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/5644346</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.5644345</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/ycharos</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">&lt;p&gt;Head-to-head comparison of available commercial antibodies against Matrin-3 by immunoblot (Western blot), immunoprecipitation and immunofluorescence.&lt;/p&gt;</description>
  </descriptions>
</resource>